Mangoceuticals, Inc. (MGRX)

USD 2.45

(-5.04%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021
Revenue 731.49 Thousand 8939.00 -
Cost of Revenue 299.99 Thousand 4089.00 -
Gross Profit 431.5 Thousand 4850.00 -
Operating Expenses 9.65 Million 1.99 Million 17.52 Thousand
Selling, General and Administrative Expenses 8.54 Million 1.99 Million 17.52 Thousand
Research and Development Expenses - - -
Other Expenses 1.1 Million - -
Cost and Expenses 9.95 Million 2 Million 17.52 Thousand
Operating Income -9.21 Million -1.99 Million -17.52 Thousand
Interest Expense - 6473.00 181.00
Income Tax Expense - -224.62 Thousand -70.08 Thousand
Earnings before Tax -9.21 Million -1.99 Million -17.7 Thousand
Net Income -9.21 Million -1.99 Million -17.7 Thousand
Earnings Per Share Basic -6.45 -0.12 -0.00
Earnings Per Share Diluted -6.45 -0.12 -0.00
Weighted Average Shares Outstanding 1.42 Million 17.31 Million 17.31 Million
Weighted Average Shares Outstanding (Diluted) 1.42 Million 17.31 Million 17.31 Million
Gross Margin 0.59 0.54 -
EBIT Margin -12.56 -222.36 -
Profit Margin -12.59 -223.52 -
EBITDA -9.18 Million -1.98 Million 52.56 Thousand
Earnings Before Tax Margin -12.60 -222.80 -

Income Statement Charts